Panostok-CT Capsule ER

Introduction

Panostok-CT ER is a prescription medication that combines two active ingredients: Cinitapride and Pantoprazole. Cinitapride is a prokinetic agent that helps improve gastrointestinal motility, while Pantoprazole is a proton pump inhibitor that reduces the production of stomach acid. This combination medication is primarily used for the treatment of conditions such as gastroesophageal reflux disease (GERD) and dyspepsia.

Uses

Panostok-CT ER is prescribed to relieve symptoms associated with GERD, such as heartburn, acid regurgitation, and difficulty swallowing. It can also be used to manage dyspepsia, which is characterized by symptoms like abdominal pain, bloating, and early satiety.

Dosage and Administration

The recommended dosage of Panostok-CT ER may vary depending on the severity of the condition and the individual patient’s response to treatment. Follow the instructions provided by your healthcare provider or pharmacist. Typically, the medication is taken orally, with or without food, once daily in the morning. The capsule should be swallowed whole and should not be chewed or crushed.

Mechanism of Action

Cinitapride in Panostok-CT ER works by stimulating the release of acetylcholine, a neurotransmitter that enhances gastrointestinal motility. This helps to improve the movement of food through the digestive system, reducing symptoms such as reflux and bloating. Pantoprazole, on the other hand, inhibits the secretion of stomach acid by irreversibly blocking the enzyme responsible for acid production. By reducing the acidity in the stomach, it helps to relieve symptoms associated with GERD and dyspepsia.

Side Effects

Common side effects may include headache, dizziness, diarrhea, and abdominal pain. These side effects are usually mild and transient, but if they persist or worsen, consult your healthcare provider.

In rare cases, serious side effects may occur, such as allergic reactions, severe abdominal pain, or signs of liver problems (e.g., yellowing of the skin or eyes, dark urine, unexplained fatigue). If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

Panostok-CT ER may interact with other medications and substances. Inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Some medications, such as certain antivirals, antifungals, and anticoagulants, may interact with Panostok-CT ER, potentially affecting its effectiveness or increasing the risk of side effects. Your healthcare provider will be able to assess the potential interactions and adjust your medication regimen accordingly.

Precautions

Before taking Panostok-CT ER, disclose your medical history and any known allergies to your healthcare provider. Inform them if you have any liver or kidney problems, as dosage adjustments may be necessary. This medication is not recommended for use in pregnant or breastfeeding women unless specifically prescribed by a healthcare provider.

Panostok-CT ER should be used with caution in patients with a history of cardiac arrhythmias or those who are taking medications that may prolong the QT interval. Follow the prescribed dosage and not exceed the recommended duration of treatment.

Storage

Panostok-CT ER should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Panostok-CT ER as directed by your healthcare provider. Do not adjust the dosage or stop taking the medication without consulting them first.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• If you experience any new or worsening symptoms while taking Panostok-CT ER, contact your healthcare provider.
• Avoid consuming alcohol while taking this medication, as it may increase the risk of certain side effects.
• If you are scheduled for any medical tests, inform the healthcare professional conducting the tests that you are taking Panostok-CT ER, as it may interfere with the results.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Pantoprazole: medicine to lower stomach acid (NHS UK) [Accessed 21 Jun. 2024] (online) Available at:
• Pantoloc Control 20mg gastro-resistant tablets (Health Professionals SmPC) Available at:
• Cinitapride (International database) (Drugs.com) [Accessed 3 Jun. 2024] (online) Available at:
• pantoprazole sodium (RX) [Accessed 11 Jun. 2024] (online) Available at:
• Pantoprazole (MedlinePlus) [Accessed 15 Jun. 2024] (online) Available at:
• González Gutiérrez ML, Rubio Pérez M, Vázquez Cortés S, Martínez González de Lema B. Cinitapride-induced exanthema. J Investig Allergol Clin Immunol. 2010;20(2):174. [Accessed 19 Jun. 2024] Available at: